DNK 333: Clinical Trials

1 trial of DNK 333, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow DNK 333: new trials by email Literature Review of DNK 333 trials Research Report on DNK 333

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of DNK333 in Patients With COPD and Cough
DNK333 100 mg twice daily, Placebo - Chronic Obstructive Pulmonary Disease
Phase 1 / Phase 2CompletedNovartis282003-09-012011-02-01

Conditions studied

Cough (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Sponsors

Novartis (1)

Countries

Netherlands (1)  ·  United Kingdom (1)